BRKR
Bruker Corporation
Healthcare — Medical Devices
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Price History
Fundamentals
| Market Cap | $9.57B |
| P/E Ratio (TTM) | - |
| Forward P/E | 25.87 |
| EPS (TTM) | $-0.24 |
| Dividend Yield | 0.32% |
| Profit Margin | -0.34% |
| Revenue Growth | 2.70% |
| ROE | -0.43% |
| Debt/Equity | 68.12 |
| Recommendation | Buy 2.1 |
| Analyst Target | $59.75 |
| Analysts | 12 |
| Next Earnings | Aug 4, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 58.3 |
| Beta | 1.29 |
| SMA 20 | $60.16 |
| SMA 40 | $58.90 |
| 52-Week High | $65.30 |
| 52-Week Low | $28.53 |
| 50-Day Avg | $57.56 |
| 200-Day Avg | $45.78 |
| Avg Volume | $2.45M |
| Volume | $1.68M |
Performance Analysis
NEUTRALBRKR presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Aug 01, 2026 05:07 UTC
Back to Screener Export Report